Melexis Resultados de beneficios anteriores
Pasado controles de criterios 3/6
Melexis ha aumentado sus beneficios a una tasa media anual de 27%, mientras que los beneficios de la industria de Semiconductor han experimentado un crecimiento de 27% anual. Los ingresos han ido creciendo a una tasa media de 17.2% al año. La rentabilidad financiera de Melexis es de 33.6%, y sus márgenes netos son de 20.6%.
Información clave
27.0%
Tasa de crecimiento de los beneficios
27.0%
Tasa de crecimiento del BPA
| Crecimiento de la industria Semiconductor | 23.8% |
| Tasa de crecimiento de los ingresos | 17.2% |
| Rentabilidad financiera | 33.6% |
| Margen neto | 20.6% |
| Próxima actualización de resultados | 05 Feb 2025 |
Actualizaciones de resultados anteriores recientes
Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations
Aug 31
Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations
Feb 15Recent updates
These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Reasonably Well
Oct 31Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91
Oct 11Should You Think About Buying Melexis NV (EBR:MELE) Now?
Oct 01Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations
Aug 31There's Reason For Concern Over Melexis NV's (EBR:MELE) Price
Aug 19Earnings Update: Melexis NV (EBR:MELE) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts
Aug 02A Look At The Fair Value Of Melexis NV (EBR:MELE)
Jul 04Is There Now An Opportunity In Melexis NV (EBR:MELE)?
Jun 20Melexis (EBR:MELE) Knows How To Allocate Capital
Jun 07Melexis (EBR:MELE) Seems To Use Debt Quite Sensibly
May 22Shareholders Will Probably Be Cautious Of Increasing Melexis NV's (EBR:MELE) CEO Compensation At The Moment
May 08Calculating The Fair Value Of Melexis NV (EBR:MELE)
Mar 27At €78.60, Is Melexis NV (EBR:MELE) Worth Looking At Closely?
Mar 14Many Would Be Envious Of Melexis' (EBR:MELE) Excellent Returns On Capital
Feb 28Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations
Feb 15Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet
Jan 02What Does Melexis NV's (EBR:MELE) Share Price Indicate?
Dec 09Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors
Nov 27Melexis (EBR:MELE) Knows How To Allocate Capital
Nov 15Calculating The Intrinsic Value Of Melexis NV (EBR:MELE)
Nov 03Melexis' (EBR:MELE) Dividend Will Be €0.91
Oct 10Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91
Sep 26Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?
Sep 17Melexis (EBR:MELE) Has Announced A Dividend Of €0.91
Sep 02Melexis (EBR:MELE) Has Announced A Dividend Of €0.91
Aug 19Melexis' (EBR:MELE) Dividend Will Be €0.91
Aug 05Melexis (EBR:MELE) Might Become A Compounding Machine
Jul 13Do Melexis' (EBR:MELE) Earnings Warrant Your Attention?
Jun 29Estimating The Intrinsic Value Of Melexis NV (EBR:MELE)
Jun 02At €99.75, Is Melexis NV (EBR:MELE) Worth Looking At Closely?
Apr 11With EPS Growth And More, Melexis (EBR:MELE) Makes An Interesting Case
Mar 27Is It Time To Consider Buying Melexis NV (EBR:MELE)?
Jan 09Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors
Dec 24Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 24Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91
Oct 18Melexis' (EBR:MELE) Dividend Will Be €0.91
Oct 04Melexis' (EBR:MELE) Dividend Will Be €0.91
Sep 20We Ran A Stock Scan For Earnings Growth And Melexis (EBR:MELE) Passed With Ease
Sep 19Melexis' (EBR:MELE) Dividend Will Be €0.91
Sep 05Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91
Aug 22Melexis (EBR:MELE) Will Pay A Dividend Of €0.91
Aug 04Is There An Opportunity With Melexis NV's (EBR:MELE) 31% Undervaluation?
Jul 11Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns
Jun 27Does Melexis (EBR:MELE) Deserve A Spot On Your Watchlist?
Jun 13Should You Think About Buying Melexis NV (EBR:MELE) Now?
Mar 01Calculating The Fair Value Of Melexis NV (EBR:MELE)
Feb 14Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns
Dec 06Should You Think About Buying Melexis NV (EBR:MELE) Now?
Nov 18Desglose de ingresos y gastos
Cómo gana y gasta dinero Melexis. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Sep 24 | 986 | 203 | 72 | 110 |
| 30 Jun 24 | 987 | 209 | 71 | 110 |
| 31 Mar 24 | 978 | 211 | 71 | 109 |
| 31 Dec 23 | 964 | 209 | 72 | 107 |
| 30 Sep 23 | 938 | 212 | 68 | 103 |
| 30 Jun 23 | 909 | 204 | 66 | 98 |
| 31 Mar 23 | 881 | 199 | 62 | 94 |
| 31 Dec 22 | 836 | 197 | 58 | 90 |
| 30 Sep 22 | 779 | 178 | 55 | 85 |
| 30 Jun 22 | 722 | 166 | 51 | 82 |
| 31 Mar 22 | 672 | 152 | 49 | 79 |
| 31 Dec 21 | 644 | 131 | 47 | 78 |
| 30 Sep 21 | 625 | 122 | 46 | 79 |
| 30 Jun 21 | 584 | 100 | 45 | 78 |
| 31 Mar 21 | 525 | 76 | 44 | 77 |
| 31 Dec 20 | 508 | 69 | 45 | 78 |
| 30 Sep 20 | 487 | 61 | 44 | 78 |
| 30 Jun 20 | 489 | 61 | 45 | 79 |
| 31 Mar 20 | 509 | 67 | 46 | 80 |
| 31 Dec 19 | 487 | 60 | 46 | 80 |
| 30 Sep 19 | 501 | 73 | 46 | 80 |
| 30 Jun 19 | 525 | 88 | 46 | 80 |
| 31 Mar 19 | 547 | 101 | 46 | 79 |
| 31 Dec 18 | 569 | 115 | 45 | 78 |
| 30 Sep 18 | 560 | 114 | 43 | 75 |
| 30 Jun 18 | 541 | 112 | 40 | 73 |
| 31 Mar 18 | 527 | 114 | 38 | 71 |
| 31 Dec 17 | 512 | 111 | 36 | 69 |
| 30 Sep 17 | 499 | 109 | 35 | 69 |
| 30 Jun 17 | 486 | 107 | 33 | 67 |
| 31 Mar 17 | 470 | 99 | 32 | 66 |
| 31 Dec 16 | 456 | 96 | 31 | 64 |
| 30 Sep 16 | 439 | 93 | 29 | 63 |
| 30 Jun 16 | 426 | 93 | 29 | 61 |
| 31 Mar 16 | 415 | 95 | 28 | 59 |
| 31 Dec 15 | 400 | 99 | 28 | 57 |
| 30 Sep 15 | 386 | 97 | 27 | 53 |
| 30 Jun 15 | 371 | 97 | 26 | 51 |
| 31 Mar 15 | 351 | 93 | 25 | 47 |
| 31 Dec 14 | 332 | 85 | 24 | 45 |
| 30 Sep 14 | 319 | 81 | 24 | 43 |
| 30 Jun 14 | 304 | 71 | 24 | 43 |
| 31 Mar 14 | 289 | 63 | 23 | 42 |
| 31 Dec 13 | 275 | 55 | 22 | 41 |
Ingresos de calidad: MELE tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio(20.6%) de MELE son inferiores a los del año pasado (22.6%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: En los últimos 5 años, los beneficios de lMELE han crecido significativamente en un 27% al año.
Acelerando crecimiento: MELE ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.
Beneficios vs. Industria: MELE tuvo un crecimiento negativo de los beneficios (-4.2%) durante el año pasado, lo que dificulta la comparación con la media de la industria Semiconductor (-11.6%).
Rentabilidad financiera
Alta ROE: La rentabilidad financiera (33.6%) de MELE se considera alta.